Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2025.09.042 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Jason C Klein und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Immunocompromised Host, Immunosuppression Therapy, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Immunosuppression is associated with a higher risk of developing cutaneous squamous cell carcinoma (CSCC) and more aggressive tumors, but its role as an independent predictor of poor outcomes remains unclear. OBJECTIVE: To determine whether immunosuppression independently predicts poor outcomes in CSCC. METHODS: This was a retrospective cohort study with pooled data from 12 international centers. Demographics, immunosuppression status, tumor characteristics, treatment, and outcomes were collected. Univariable and multivariable marginal Fine and Gray competing risk analyses were performed. Subgroup multivariable analyses were performed on the organ transplant and chronic lymphocytic leukemia cohorts. RESULTS: A total of 11,930 patients with 18,760 tumors (14,766 in immunocompetent and 3994 in immunosuppressed) were included. Immunosuppressed patients had a higher prevalence of high-risk tumor features and poor disease outcomes. On multivariable analysis, immunosuppression was independently associated with local recurrence (LR), distant metastasis, disease-specific death (DSD), and major poor outcomes. Organ transplantation was predictive of LR, distant metastasis, and DSD, whereas chronic lymphocytic leukemia independently predicted LR, DSD, and major poor outcomes. LIMITATIONS: A retrospective design, potential for data heterogeneity. CONCLUSIONS: Immunosuppression is an independent risk factor for major poor outcomes in CSCC and should be included in risk nomograms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Dermatology, The Ohio State University Medical Center, Columbus, Ohio. Electronic address: Kathryn.Shahwan@osumc.edu.
- University of Texas Southwestern Medical School, Dallas, Texas.
- The Ohio State University College of Medicine, Columbus, Ohio.
- Department of Dermatology, Stanford University, Palo Alto, California.
- Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Zitieren
APA
Klein, J. C., Shahwan, K. T., Petric, U. B., Mallela, T., Voller, L., Ruiz, E., Ran, N., Granger, E. E., Koyfman, S., Vidimos, A., Wysong, A., Hirotsu, K., Carucci, J. A., Carter, J. B., Cañueto, J., Girardi, F. M., Mangold, A. R., Brodland, D. G., Zitelli, J. A., …, & Carr, D. R. (2026). Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.09.042
Vancouver
Klein JC, Shahwan KT, Petric UB, Mallela T, Voller L, Ruiz E, et al. Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.09.042
BibTeX
@article{Klein2026,
author = {Klein, Jason C and Shahwan, Kathryn T and Petric, Ursa Bezan and Mallela, Teja and Voller, Lindsey and Ruiz, Emily and Ran, Nina and Granger, Emily E and Koyfman, Shlomo and Vidimos, Allison and Wysong, Ashley and Hirotsu, Kelsey and Carucci, John A and Carter, Joi B and Cañueto, Javier and Girardi, Fabio Muradás and Mangold, Aaron R and Brodland, David G and Zitelli, John A and Willenbrink, Tyler J and Lotter, William and Jeanselme, Vincent and Nikahd, Melica and Nijhawan, Rajiv I and Srivastava, Divya and Carr, David R},
title = {Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2025.09.042}
}
EUVIMED